Attitude before COX-2 selective inhibitors
López-Zaragoza, J.é L.; Gulias-Herrero, A.; Gutiérrez-Cirlos, C.; Cárdenas-Cortés, M.d.C.; Carrillo-Maravilla, E.; Terrazas-Solís, H.; Catzin-Kuhlmann, A.és.; Flores-Rebollar, A.; Villegas-Jiménez, A.
Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 57(1): 6-12
2005
ISSN/ISBN: 0034-8376 PMID: 15981953 Document Number: 586096
Document emailed within 1 workday
Related Documents
Posternak, M.A.; Zimmerman, M. 2005: Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study Journal of Clinical Psychiatry 66(6): 705-707Joshi, A. 2018: Selective Serotonin Re-uptake Inhibitors: An overview Psychiatria Danubina 30(Suppl 7): 605-609
Kawai, S. 2002: Recent development of selective cyclooxygenase-2 inhibitors Nihon Rinsho. Japanese Journal of Clinical Medicine 60(12): 2370-2377
Cannavo, D. 2002: Use of neuraxial anesthesia with selective factor Xa inhibitors American Journal of Orthopedics 31(11 Suppl): 21-23
Kvande, K.T.; Madsen, S. 2001: Selective serotonin uptake inhibitors and pancreatitis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(2): 177-178
DeVane, C.L. 1992: Pharmacokinetics of the selective serotonin reuptake inhibitors Journal of Clinical Psychiatry 53 Suppl: 13-20
Ho, L.; Pasinetti, G.Maria. 2001: The potential of selective COX-2 inhibitors in inflammatory and other diseases Drugs of Today 37(3): 181-185
Dang, C.T.; Shapiro, C.L.; Hudis, C.A. 2002: Potential role of selective COX-2 inhibitors in cancer management Oncology 16(5 Suppl 4: 30-36
Ahmed, W.; Khan, I.A.; Arshad, M.N.; Siddiqui, W.A.; Haleem, M.A.; Azim, M.K. 2013: Identification of Sulfamoylbenzamide derivatives as selective Cathepsin D inhibitors Pakistan Journal of Pharmaceutical Sciences 26(4): 687-690
Mayer, L.E.; Walsh, B.T. 1998: The use of selective serotonin reuptake inhibitors in eating disorders Journal of Clinical Psychiatry 59(Suppl): 28-34
Schuster, I.; Egger, H.; Herzig, G.; Reddy, G.S.; Schmid, J.A.; Schüssler, M.; Vorisek, G. 2006: Selective inhibitors of vitamin D metabolism--new concepts and perspectives Anticancer Research 26(4a): 2653-2668
Dudek, D.; Zieba, A.; Siwek, M.; Wróbel, A. 2004: Selective serotonin reuptake inhibitors--current knowledge Psychiatria Polska 38(3): 507-524
Mahendran, R. 2006: The risk of suicidality with selective serotonin reuptake inhibitors Annals of the Academy of Medicine Singapore 35(2): 96-99
Wong, D.T.; Fuller, R.W.; Robertson, D.W. 1990: Fluoxetine and its two enantiomers as selective serotonin uptake inhibitors Acta Pharmaceutica Nordica 2(3): 171-180
Bhowmik, D.; Tiwari, S.C. 2004: Selective COX-2 inhibitors should be used judiciously in the presence of renal impairment Journal of the Indian Medical Association 102(4): 225
Stanchev, B.S.; Grokhovskiĭ, S.L.; Khorlin, A.A.; Gottikh, B.P.; Zhuze, A.L. 1986: Netropsin, distamycin A, bis-netropsins as selective inhibitors of restrictases and DNAse i Molekuliarnaia Biologiia 20(6): 1614-1624
Finberg, J.P. 1995: Pharmacology of reversible and selective inhibitors of monoamine oxidase type A Acta Psychiatrica Scandinavica. Supplementum 386: 8-13
Nakielny, J.; Eckett, S. 1994: Selective serotonin reuptake inhibitors. Calculation of costs is incorrect Bmj 309(6961): 1082-3; Author Reply 1085
Cailleux, N.; Marie, I.; Chrétien, M.H.; Noblet, C.; Lévesque, H.; Courtois, H. 2000: Spontaneous hematoma: thoughts about selective serotonin uptake inhibitors Journal des Maladies Vasculaires 25(1): 63-64
Harguindey, S.; Arranz, J.L.; Wahl, M.L.; Orive, G.; Reshkin, S.J. 2009: Proton transport inhibitors as potentially selective anticancer drugs Anticancer Research 29(6): 2127-2136